Skip to main content
Top
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Research article

Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study

Authors: Betania Allen-Leigh, Patricia Uribe-Zúñiga, Leith León-Maldonado, Brandon J. Brown, Attila Lörincz, Jorge Salmeron, Eduardo Lazcano-Ponce

Published in: BMC Cancer | Issue 1/2017

Login to get access

Abstract

Background

Data is needed about barriers to self-collection of Human Papillomavirus (HPV) samples and cytology among low-income, disadvantaged women living in rural areas of lower-income countries as these women are at increased risk of cervical cancer mortality.

Methods

Individual interviews (n = 29), focus groups (n = 7, 5–11 participants) and discussion groups (n = 2, 18–25 participants) were organized with women from three indigenous ethnic groups residing in rural areas in Mexico, after they were provided with free, self-sampled HPV tests. These groups are low-income, underserved by healthcare and have historically been on the receiving end of racism and social exclusion. Descriptive, qualitative content analysis was done, including two cycles of coding.

Results

Interview and focus/discussion group data indicate women had limited understanding of HPV’s role in cervical cancer etiology. They identified HPV’s existence, that cytology detects cervical cancer, the need for regular testing and that cervical cancer is sexually transmitted. Organizational barriers to clinic-based cytology included irregular supplies of disposable speculums, distance to clinics and lack of clear communication by healthcare personnel. Women considered self-collected HPV-testing easy, less embarrassing and less painful than cytology, an opportunity for self-care and most felt they understood how to take a self-sample after a 20-min explanation. Some women feared hurting themselves when taking the self-sample or that they would take the sample incorrectly, which they worried would make the test useless. Attending HPV-testing in groups facilitated use by allowing women to discuss their doubts and fears before doing self-collection of the sample or to ask other women who were the first to do the self-sampling what the experience had been like (whether it hurt and how easy it was). Lack of indoor bathrooms was a barrier to doing HPV self-sampling at home, when those homes were resource-poor (one-room dwellings).

Conclusions

Low-income, indigenous Mexican women residing in rural, underserved areas identified their need for cervical cancer screening but encountered multiple barriers to cytology-based screening. They found a number of advantages of HPV self-sampled tests. Employing self-collected HPV-testing instead of cytology could resolve some but not all gender-related, organizational or technical quality-of-care issues within cervical cancer detection and control programs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011 Dec;22(12):2675–86.CrossRefPubMed Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011 Dec;22(12):2675–86.CrossRefPubMed
2.
go back to reference Tsu VD, Levin CE. Making the case for cervical cancer prevention: what about equity? Reprod Health Matters. 2008 Nov;16(32):104–12.CrossRefPubMed Tsu VD, Levin CE. Making the case for cervical cancer prevention: what about equity? Reprod Health Matters. 2008 Nov;16(32):104–12.CrossRefPubMed
3.
go back to reference Bray F, Piñeros M. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Publica Mex. 2016;58:104–17.CrossRefPubMed Bray F, Piñeros M. Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. Salud Publica Mex. 2016;58:104–17.CrossRefPubMed
4.
go back to reference Palacio-Mejía LS, Rangel-Gómez G, Hernández-Avila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex. 2003;45:S315–25.CrossRefPubMed Palacio-Mejía LS, Rangel-Gómez G, Hernández-Avila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex. 2003;45:S315–25.CrossRefPubMed
5.
go back to reference Reath J, Carey M. Breast and cervical cancer in indigenous women-overcoming barriers to early detection. Aust Fam Physician. 2008;37(3):178–82.PubMed Reath J, Carey M. Breast and cervical cancer in indigenous women-overcoming barriers to early detection. Aust Fam Physician. 2008;37(3):178–82.PubMed
6.
go back to reference Read CM, Bateson DJ. Marrying research, clinical practice and cervical screening in Australian aboriginal women in western new South Wales, Australia. Rural Remote Health. 2009;9(2):1117.PubMed Read CM, Bateson DJ. Marrying research, clinical practice and cervical screening in Australian aboriginal women in western new South Wales, Australia. Rural Remote Health. 2009;9(2):1117.PubMed
7.
go back to reference Palacio-Mejía LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-Avila M. Regional differences in breast and cervical cancer mortality in Mexico between 1979-2006. Salud Publica Mex. 2009;51:s208–19.CrossRefPubMed Palacio-Mejía LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-Avila M. Regional differences in breast and cervical cancer mortality in Mexico between 1979-2006. Salud Publica Mex. 2009;51:s208–19.CrossRefPubMed
8.
go back to reference Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health. 2014 Sep-Oct;80(5):412–7.CrossRefPubMed Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health. 2014 Sep-Oct;80(5):412–7.CrossRefPubMed
9.
go back to reference Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Alliance for cervical cancer prevention cost working group. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;17(353):2158–68.CrossRef Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahé C, et al. Alliance for cervical cancer prevention cost working group. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;17(353):2158–68.CrossRef
10.
go back to reference Balasubramanian A, Kulasingam SL, Baer A, Hughes JP, Myers ER, Mao C, et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis. 2010 Jul;14(3):185–95.CrossRefPubMedPubMedCentral Balasubramanian A, Kulasingam SL, Baer A, Hughes JP, Myers ER, Mao C, et al. Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis. 2010 Jul;14(3):185–95.CrossRefPubMedPubMedCentral
11.
go back to reference Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol. 2009 Dec;33(6):446–50.CrossRefPubMed Bhatla N, Dar L, Patro AR, Kumar P, Kriplani A, Gulati A, et al. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? Cancer Epidemiol. 2009 Dec;33(6):446–50.CrossRefPubMed
12.
go back to reference Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, et al. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes Control. 2011 Feb;22(2):261–72.CrossRefPubMed Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, et al. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes Control. 2011 Feb;22(2):261–72.CrossRefPubMed
13.
go back to reference Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868–73.CrossRefPubMed Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet. 2011;378(9806):1868–73.CrossRefPubMed
14.
go back to reference Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51(16):2375–85.CrossRefPubMed Verdoodt F, Jentschke M, Hillemanns P, Racey CS, Snijders PJ, Arbyn M. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials. Eur J Cancer. 2015;51(16):2375–85.CrossRefPubMed
15.
go back to reference Racey CS, Withrow DR, Gesink D, Self-collected HPV. Testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health. 2013;104(2):e159–66.PubMed Racey CS, Withrow DR, Gesink D, Self-collected HPV. Testing improves participation in cervical cancer screening: a systematic review and meta-analysis. Can J Public Health. 2013;104(2):e159–66.PubMed
16.
go back to reference Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, et al. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomark Prev. 2008 Oct;17(10):2808–17.CrossRef Lazcano-Ponce E, Palacio-Mejia LS, Allen-Leigh B, Yunes-Diaz E, Alonso P, Schiavon R, et al. Decreasing cervical cancer mortality in Mexico: effect of Papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomark Prev. 2008 Oct;17(10):2808–17.CrossRef
18.
go back to reference Gómez-Dantés H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman-Retana O, Montero P, González-Robledo MC, Fitzmaurice C, Pain A, Allen C, Dicker DJ, Hamavid H, López A, Murray C, Naghavi M, Lozano R. The burden of cancer in Mexico, 1990-2013. Salud Publica Mex. 2016;58:118–31.CrossRefPubMed Gómez-Dantés H, Lamadrid-Figueroa H, Cahuana-Hurtado L, Silverman-Retana O, Montero P, González-Robledo MC, Fitzmaurice C, Pain A, Allen C, Dicker DJ, Hamavid H, López A, Murray C, Naghavi M, Lozano R. The burden of cancer in Mexico, 1990-2013. Salud Publica Mex. 2016;58:118–31.CrossRefPubMed
21.
go back to reference Dirección General de Información en Salud. Secretaría de Salud, Sistema en Línea Cubos. Defunciones SS/INEGI. Dirección General de Información en Salud. Secretaría de Salud, Sistema en Línea Cubos. Defunciones SS/INEGI.
22.
go back to reference Sánchez-Barriga JJ. Tendencias de mortalidad por cáncer cervicouterino en las siete regiones socioeconómicas y en las 32 entidades federativas de México en los años 2000-2008. Gac Med Mex. 2012;148:42–51.PubMed Sánchez-Barriga JJ. Tendencias de mortalidad por cáncer cervicouterino en las siete regiones socioeconómicas y en las 32 entidades federativas de México en los años 2000-2008. Gac Med Mex. 2012;148:42–51.PubMed
23.
go back to reference Patton MQ. Qualitative evaluation and research methods. 2nd ed. Newbury Park, California: Sage Publications; 1990. Patton MQ. Qualitative evaluation and research methods. 2nd ed. Newbury Park, California: Sage Publications; 1990.
24.
go back to reference Kahn JA, Slap GB, Bernstein DI, Kahn JA, Slap GB, Bernstein DI, et al. Personal meaning of human papillomavirus and pap test results in adolescent and young adult women. Health Psychol. 2007;26:192–200.CrossRefPubMed Kahn JA, Slap GB, Bernstein DI, Kahn JA, Slap GB, Bernstein DI, et al. Personal meaning of human papillomavirus and pap test results in adolescent and young adult women. Health Psychol. 2007;26:192–200.CrossRefPubMed
25.
go back to reference McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect. 2006;82(2):169–74.CrossRefPubMedPubMedCentral McCaffery K, Waller J, Nazroo J, Wardle J. Social and psychological impact of HPV testing in cervical screening: a qualitative study. Sex Transm Infect. 2006;82(2):169–74.CrossRefPubMedPubMedCentral
26.
go back to reference Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC Jr. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Women's Health. 2005;14:721–8.CrossRef Anhang R, Nelson JA, Telerant R, Chiasson MA, Wright TC Jr. Acceptability of self-collection of specimens for HPV DNA testing in an urban population. J Women's Health. 2005;14:721–8.CrossRef
27.
go back to reference Waller J, McCaffery K, Nazroo J, Wardle J. Making sense of information about HPV in cervical screening: a qualitative study. Br J Cancer. 2005;92:265–70.CrossRefPubMedPubMedCentral Waller J, McCaffery K, Nazroo J, Wardle J. Making sense of information about HPV in cervical screening: a qualitative study. Br J Cancer. 2005;92:265–70.CrossRefPubMedPubMedCentral
28.
go back to reference Augé M, Herzlich C, editors. The meaning of illness. In: Anthropology, History and Sociology: Harwood Academic Publishers, Sydney; 1995. p. 231. Augé M, Herzlich C, editors. The meaning of illness. In: Anthropology, History and Sociology: Harwood Academic Publishers, Sydney; 1995. p. 231.
29.
go back to reference Taïeb O, Heidenreich F, Baubet T, Moro MR. Donner un sens à la maladie: de l’anthropologie médicale à l’épidémiologie culturelle. Med Mal Infect. 2005;35:173–85.CrossRefPubMed Taïeb O, Heidenreich F, Baubet T, Moro MR. Donner un sens à la maladie: de l’anthropologie médicale à l’épidémiologie culturelle. Med Mal Infect. 2005;35:173–85.CrossRefPubMed
30.
go back to reference Masculin HF. Féminin. La pensée de la différence. Paris: O. Jacob; 1996. Masculin HF. Féminin. La pensée de la différence. Paris: O. Jacob; 1996.
31.
go back to reference Ortner S. Making gender: the politics and erotics of culture. Boston: Beacon Press; 1996. p. 262. Ortner S. Making gender: the politics and erotics of culture. Boston: Beacon Press; 1996. p. 262.
32.
go back to reference Miles MB, Huberman AM. Qualitative data analysis. In: An expanded sourcebook. Thousand Oaks: SAGE; 1994. Miles MB, Huberman AM. Qualitative data analysis. In: An expanded sourcebook. Thousand Oaks: SAGE; 1994.
33.
go back to reference León-Maldonado L, Wentzell E, Brown B, Allen-Leigh B, Torres-Ibarra L, Salmerón J, et al. Perceptions and experiences of human papillomavirus (HPV) infection and testing among low-income Mexican women. PLoS One. 2016;11(5):e0153367. León-Maldonado L, Wentzell E, Brown B, Allen-Leigh B, Torres-Ibarra L, Salmerón J, et al. Perceptions and experiences of human papillomavirus (HPV) infection and testing among low-income Mexican women. PLoS One. 2016;11(5):e0153367.
34.
go back to reference Huynh J, Howard M, Lytwyn A. Self-collection for vaginal human papillomavirus testing: systematic review of studies asking women their perceptions. J Low Genit Tract Dis. 2010;14(4):356–62.CrossRefPubMed Huynh J, Howard M, Lytwyn A. Self-collection for vaginal human papillomavirus testing: systematic review of studies asking women their perceptions. J Low Genit Tract Dis. 2010;14(4):356–62.CrossRefPubMed
35.
go back to reference León-Maldonado L, Allen-Leigh B, Lazcano-Ponce E. Consejería en la detección de VPH como prueba de tamizaje de cáncer cervical: un estudio cualitativo sobre necesidades de mujeres de Michoacán, México. [Counseling for HPV detection when used to screen for cervical cancer: a qualitative study on the needs of women from Michoacan, Mexico]. Salud Publica Mex. 2014;56:519–27.CrossRefPubMed León-Maldonado L, Allen-Leigh B, Lazcano-Ponce E. Consejería en la detección de VPH como prueba de tamizaje de cáncer cervical: un estudio cualitativo sobre necesidades de mujeres de Michoacán, México. [Counseling for HPV detection when used to screen for cervical cancer: a qualitative study on the needs of women from Michoacan, Mexico]. Salud Publica Mex. 2014;56:519–27.CrossRefPubMed
36.
go back to reference Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DA, Meijer CJ, High-risk HPV. Testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer. 2013;132(10):2223–36.CrossRefPubMed Snijders PJ, Verhoef VM, Arbyn M, Ogilvie G, Minozzi S, Banzi R, van Kemenade FJ, Heideman DA, Meijer CJ, High-risk HPV. Testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer. 2013;132(10):2223–36.CrossRefPubMed
37.
go back to reference Crofts V, Flahault E, Tebeu PM, Untiet S, Fosso GK, Boulvain M, Vassilakos P, Petignat P. Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health. 2015;7:149–54.CrossRefPubMedPubMedCentral Crofts V, Flahault E, Tebeu PM, Untiet S, Fosso GK, Boulvain M, Vassilakos P, Petignat P. Education efforts may contribute to wider acceptance of human papillomavirus self-sampling. Int J Womens Health. 2015;7:149–54.CrossRefPubMedPubMedCentral
38.
go back to reference Berner A, Hassel SB, Tebeu PM, Untiet S, Kengne-Fosso G, Navarria I, Boulvain M, Vassilakos P, Petignat P. Human papillomavirus self-sampling in Cameroon: women's uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis. 2013;17(3):235–41.CrossRefPubMed Berner A, Hassel SB, Tebeu PM, Untiet S, Kengne-Fosso G, Navarria I, Boulvain M, Vassilakos P, Petignat P. Human papillomavirus self-sampling in Cameroon: women's uncertainties over the reliability of the method are barriers to acceptance. J Low Genit Tract Dis. 2013;17(3):235–41.CrossRefPubMed
39.
go back to reference Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, Wardle J. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen. 2006;13(4):208–13.CrossRefPubMed Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Austin J, Wardle J. Acceptability of unsupervised HPV self-sampling using written instructions. J Med Screen. 2006;13(4):208–13.CrossRefPubMed
40.
go back to reference Penaranda E, Molokwu J, Flores S, Byrd T, Brown L, Shokar N. Women's attitudes toward Cervicovaginal self-sampling for high-risk HPV infection on the US-Mexico border. J Low Genit Tract Dis. 2015;19(4):323–8.CrossRefPubMedPubMedCentral Penaranda E, Molokwu J, Flores S, Byrd T, Brown L, Shokar N. Women's attitudes toward Cervicovaginal self-sampling for high-risk HPV infection on the US-Mexico border. J Low Genit Tract Dis. 2015;19(4):323–8.CrossRefPubMedPubMedCentral
41.
go back to reference Racey CS, Gesink DC. Barriers and facilitators to cervical cancer screening among women in rural Ontario, Canada: the role of self-collected HPV testing. J Rural Health. 2016;32(2):136–45.CrossRefPubMed Racey CS, Gesink DC. Barriers and facilitators to cervical cancer screening among women in rural Ontario, Canada: the role of self-collected HPV testing. J Rural Health. 2016;32(2):136–45.CrossRefPubMed
42.
go back to reference Scott JC, Conner DA, Venohr I, Gade G, McKenzie M, Kramer AM, et al. Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: a 2-year randomized trial of the cooperative health care clinic. J Am Geriatr Soc. 2004 Sep;52(9):1463–70.CrossRefPubMed Scott JC, Conner DA, Venohr I, Gade G, McKenzie M, Kramer AM, et al. Effectiveness of a group outpatient visit model for chronically ill older health maintenance organization members: a 2-year randomized trial of the cooperative health care clinic. J Am Geriatr Soc. 2004 Sep;52(9):1463–70.CrossRefPubMed
43.
go back to reference Schellinger MM, Abernathy MP, Amerman B, May C, Foxlow LA, Carter AL, et al. Improved outcomes for Hispanic women with gestational diabetes using the centering pregnancy(©) group prenatal care model. Matern Child Health J. 2016 Jul;16 [Epub ahead of print] Schellinger MM, Abernathy MP, Amerman B, May C, Foxlow LA, Carter AL, et al. Improved outcomes for Hispanic women with gestational diabetes using the centering pregnancy(©) group prenatal care model. Matern Child Health J. 2016 Jul;16 [Epub ahead of print]
44.
go back to reference Ickovics JR, Earnshaw V, Lewis JB, Kershaw TS, Magriples U, Stasko E, et al. Cluster randomized controlled trial of group prenatal care: perinatal outcomes among adolescents in New York City health centers. Am J Public Health. 2016;106(2):359–65.CrossRefPubMedPubMedCentral Ickovics JR, Earnshaw V, Lewis JB, Kershaw TS, Magriples U, Stasko E, et al. Cluster randomized controlled trial of group prenatal care: perinatal outcomes among adolescents in New York City health centers. Am J Public Health. 2016;106(2):359–65.CrossRefPubMedPubMedCentral
45.
go back to reference Earnshaw VA, Rosenthal L, Cunningham SD, Kershaw T, Lewis J, Rising SS, et al. Exploring group composition among young, urban women of color in prenatal care: implications for satisfaction, engagement, and group attendance. Womens Health Issues. 2016 Jan-Feb;26(1):110–5.CrossRefPubMed Earnshaw VA, Rosenthal L, Cunningham SD, Kershaw T, Lewis J, Rising SS, et al. Exploring group composition among young, urban women of color in prenatal care: implications for satisfaction, engagement, and group attendance. Womens Health Issues. 2016 Jan-Feb;26(1):110–5.CrossRefPubMed
46.
go back to reference Han HR, Kim J, Lee JE, Hedlin HK, Song H, Song Y, et al. Interventions that increase use of pap tests among ethnic minority women: a meta-analysis. Psychooncology. 2011;20(4):341–51.CrossRefPubMed Han HR, Kim J, Lee JE, Hedlin HK, Song H, Song Y, et al. Interventions that increase use of pap tests among ethnic minority women: a meta-analysis. Psychooncology. 2011;20(4):341–51.CrossRefPubMed
47.
50.
go back to reference Gage JC, Ajenifuja KO, Wentzensen N, Adepiti AC, Stoler M, Eder PS, et al. Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int J Cancer. 2012;131(12):2903–9.CrossRefPubMedPubMedCentral Gage JC, Ajenifuja KO, Wentzensen N, Adepiti AC, Stoler M, Eder PS, et al. Effectiveness of a simple rapid human papillomavirus DNA test in rural Nigeria. Int J Cancer. 2012;131(12):2903–9.CrossRefPubMedPubMedCentral
51.
go back to reference Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, et al. Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA study. Salud Publica Mex. 2016;58:197–210.CrossRefPubMed Torres-Ibarra L, Lazcano-Ponce E, Franco EL, Cuzick J, Hernández-Ávila M, Lorincz A, et al. Triage strategies in cervical cancer detection in Mexico: methods of the FRIDA study. Salud Publica Mex. 2016;58:197–210.CrossRefPubMed
52.
go back to reference Salmerón J, Torres-Ibarra L, Bosch FX, Cuzick J, Lörincz A, Wheeler CM, et al. HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan study in Mexico. Salud Publica Mex. 2016;58:211–9.CrossRefPubMed Salmerón J, Torres-Ibarra L, Bosch FX, Cuzick J, Lörincz A, Wheeler CM, et al. HPV vaccination impact on a cervical cancer screening program: methods of the FASTER-Tlalpan study in Mexico. Salud Publica Mex. 2016;58:211–9.CrossRefPubMed
Metadata
Title
Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study
Authors
Betania Allen-Leigh
Patricia Uribe-Zúñiga
Leith León-Maldonado
Brandon J. Brown
Attila Lörincz
Jorge Salmeron
Eduardo Lazcano-Ponce
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3723-5

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine